Sep 05, 2018
Neurocrine Biosciences to Present at the Morgan Stanley 16th Annual Global Healthcare Conference
Aug 22, 2018
AbbVie Announces Positive Topline Results from Phase 3 Extension Study Evaluating Investigational Elagolix in Women with Uterine Fibroids
Jul 31, 2018
Neurocrine Biosciences Reports Second Quarter 2018 Financial Results
Jul 24, 2018
AbbVie Receives U.S. FDA Approval of ORILISSA(TM) (elagolix) for the Management of Moderate to Severe Pain Associated with Endometriosis
Jul 10, 2018
Neurocrine Biosciences Announces Conference Call and Webcast of Second Quarter 2018 Financial Results
Jun 08, 2018
Chief Executive Officer of Neurocrine Biosciences, Kevin Gorman, Ph.D., Named EY Entrepreneur Of The Year® 2018 San Diego
May 09, 2018
Neurocrine Biosciences to Present at the Bank of America Merrill Lynch 2018 Healthcare Conference
Apr 27, 2018
AbbVie Presents New Investigational Data for Elagolix at the 2018 American College of Obstetricians and Gynecologists (ACOG) Annual Meeting
Apr 23, 2018
Neurocrine Biosciences Announces Conference Call and Webcast of First Quarter 2018 Financial Results
Apr 10, 2018
AbbVie and Neurocrine Biosciences Announce PDUFA Target Date of Q3 2018 for Elagolix in Endometriosis-Associated Pain
Mar 13, 2018
AbbVie Announces Positive Topline Results from Second Phase 3 Study Evaluating Investigational Elagolix in Women with Uterine Fibroids
Mar 07, 2018
Neurocrine Biosciences to Present at Upcoming Healthcare Conferences
Feb 21, 2018
AbbVie Announces Positive Topline Results from Phase 3 Study Evaluating Investigational Elagolix in Women with Uterine Fibroids
Feb 13, 2018
Neurocrine Biosciences Reports Fourth Quarter and Year-End 2017 Financial Results and Provides Investor Update for 2018
Feb 08, 2018
Neurocrine Biosciences to Present at the Leerink Partners 7th Annual Global Healthcare Conference
Feb 06, 2018
Neurocrine Biosciences Announces Conference Call and Webcast of Fourth Quarter and Year-End 2017 Financial Results
Jan 07, 2018
Neurocrine Biosciences Announces Retirement of Christopher O'Brien, M.D., and Appointment of Eiry W. Roberts, M.D., as Chief Medical Officer
Jan 07, 2018
Neurocrine Biosciences Provides Preliminary Fourth Quarter and Full-Year 2017 Sales Results and 2018 Program Milestones
Jan 02, 2018
Neurocrine Biosciences to Present at the 36th Annual J.P. Morgan Healthcare Conference
Dec 07, 2017
Neurocrine Biosciences to Present at the BMO Capital Markets 2017 Prescriptions for Success Healthcare Conference